CytomX Therapeutics, Inc. CTMX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2015-10-08
CytomX Therapeutics, Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Ogden Christopher | Chief Financial Officer | 2026-06-15 | Sell | 1,624 | $3.05 |
| Chu Yu-Waye | Chief Medical Officer | 2026-03-17 | Sell | 21,279 | $6.42 |
| McCarthy Sean A. | CEO | 2026-03-17 | Sell | 118,969 | $6.42 |
Source: SEC EDGAR filings · CIK 0001501989 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.